Catalyst event

SK Biopharmaceuticals Co Ltd (326030)

From Akros SCHK HK-Korea Quality Factor Index (ASHKQLT)

Q2 2026 earnings release is scheduled.

Korean translation

2026년 2분기 실적 발표 예정됨.